We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.08B
AUM Growth
-$99.6M
Cap. Flow
-$85.6M
Cap. Flow %
-7.95%
Top 10 Hldgs %
22.85%
Holding
1,895
New
210
Increased
564
Reduced
645
Closed
335

Top Buys

Rank Stock Value
1
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$30.3M
2
BND icon
Vanguard Total Bond Market
BND
+$11.6M
3
MA icon
Mastercard
MA
+$5.33M
4
COP icon
ConocoPhillips
COP
+$4.99M
5
EL icon
Estee Lauder
EL
+$4.27M

Top Sells

Rank Stock Value
1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$51.6M
2
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$45.1M
3
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$12.8M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$7.91M
5
C icon
Citigroup
C
+$7.42M

Sector Composition

Rank Sector Weight
1 Financials 15.39%
2 Technology 13.91%
3 Healthcare 10.79%
4 Consumer Discretionary 8.13%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRNE
1501
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
223
-1,084
-83% -$7.71K
CFMS
1502
DELISTED
Conformis, Inc. Common Stock
CFMS
$1K ﹤0.01%
26
+11
+73% +$462
ALNA
1503
DELISTED
Allena Pharmaceuticals
ALNA
$1K ﹤0.01%
+104
New +$869
EPZM
1504
DELISTED
Epizyme, Inc
EPZM
$1K ﹤0.01%
73
– –
CALA
1505
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
6
-15
-71% -$2.34K
ADXS
1506
DELISTED
Advaxis Inc
ADXS
$1K ﹤0.01%
30
+1
+3% +$37
TLGT
1507
DELISTED
Teligent, Inc
TLGT
$1K ﹤0.01%
33
-21
-39% -$668
SBBP
1508
DELISTED
Strongbridge Biopharma plc.
SBBP
$1K ﹤0.01%
+101
New +$756
CBMG
1509
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$1K ﹤0.01%
53
-496
-90% -$9.08K
MR
1510
DELISTED
Montage Resources Corporation Common Stock
MR
$1K ﹤0.01%
39
+12
+44% +$345
INWK
1511
DELISTED
InnerWorkings, Inc.
INWK
$1K ﹤0.01%
159
– –
MJCO
1512
DELISTED
Majesco
MJCO
$1K ﹤0.01%
182
– –
ENT
1513
DELISTED
Global Eagle Entertainment Inc.
ENT
$1K ﹤0.01%
+24
New +$1.13K
TTPH
1514
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1K ﹤0.01%
+21
New +$1.84K
SDRL
1515
DELISTED
Seadrill Limited Common Stock
SDRL
$1K ﹤0.01%
13
– –
STML
1516
DELISTED
Stemline Therapeutics, Inc.
STML
$1K ﹤0.01%
90
-254
-74% -$3.96K
RRTS
1517
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$1K ﹤0.01%
+11
New +$1.42K
RARX
1518
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1K ﹤0.01%
+237
New +$1.69K
LTS
1519
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$1K ﹤0.01%
285
-1,215
-81% -$3.94K
ENFC
1520
DELISTED
Entegra Financial Corp.
ENFC
$1K ﹤0.01%
37
-163
-82% -$4.65K
VSI
1521
DELISTED
Vitamin Shoppe Inc.
VSI
$1K ﹤0.01%
208
-517
-71% -$2.25K
AMBR
1522
DELISTED
Amber Road Inc
AMBR
$1K ﹤0.01%
91
-98
-52% -$831
INSY
1523
DELISTED
Insys Therapeutics, Inc.
INSY
$1K ﹤0.01%
162
-193
-54% -$1.59K
ICON
1524
DELISTED
Iconix Brand Group, Inc.
ICON
$1K ﹤0.01%
114
-55
-33% -$740
KERX
1525
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1K ﹤0.01%
+198
New +$922
59 60
61
62 63

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $1.75B AUM 26.24% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.73B AUM 17.74% 1-Year Est. Return
NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return

Meeder Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Meeder Asset Management held 1,895 positions worth $1.08B, down 8.5% from $1.18B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meeder Asset Management withdrew a net $85.6M in Q1 2018, closing 335 positions and reducing 645 holdings. Its most notable exit was Prologis, an estimated $4.69M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Meeder Asset Management opened a new position in Vanguard Intermediate-Term Corporate Bond ETF worth $30M.

  • Meeder Asset Management's largest Q1 2018 buy was Vanguard Intermediate-Term Corporate Bond ETF: 354,159 shares worth $30M.
  • Meeder Asset Management added most to Vanguard Total Bond Market in Q1 2018, an estimated $11.6M increase.
  • Meeder Asset Management's biggest Q1 2018 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $51.6M.
  • Meeder Asset Management fully exited Prologis in Q1 2018, selling an estimated $4.69M.
  • Meeder Asset Management's ten largest holdings make up 23% of its $1.08B portfolio in Q1 2018.
  • Meeder Asset Management opened 210 new positions and closed 335 in Q1 2018.
  • Meeder Asset Management's portfolio value fell 8.5% quarter-over-quarter to $1.08B.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.